The European Society of Urogenital Radiology (ESUR) has released a print version of its most recent guidelines for the use of iodine-based contrast media.
First published online on 30 August in European Radiology, the guidelines affirm that multiple myeloma and monoclonal gammopathies are not contraindications for iodinated contrast agents.